| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.38 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |